Related Experiment Video
Updated: Jan 1, 2026

12:17
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
11.7K
Late ventricular standstill following an elective TAVI
Peter Wheen1, Richard Armstrong2, Andrew Maree2
1School of Medicine, Trinity College Dublin, Dublin, Ireland peter.wheen@gmail.com.
BMJ Case Reports
|December 20, 2019
Summary
Transcatheter aortic valve implantation (TAVI) can unexpectedly lead to pacemaker needs, even in low-risk patients. Conduction disease may emerge days after TAVI, highlighting the need for vigilant monitoring.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Electrophysiology
Background:
- Transcatheter aortic valve implantation (TAVI) is a common procedure for aortic stenosis.
- Permanent pacemaker implantation is a known complication of TAVI, often due to conduction system compromise.
- Predictive factors for post-TAVI conduction disease include baseline ECG abnormalities and specific TAVI device types.
Observation:
- This case report details a patient who developed significant conduction disease requiring emergency pacemaker implantation after TAVI.
- The patient presented with low-risk clinical features, a normal baseline ECG, and received a low-risk TAVI valve.
- Conduction abnormalities were unexpectedly delayed, manifesting over 72 hours post-procedure despite initial normal ECGs and telemetry.
Findings:
- Delayed onset of severe conduction disease post-TAVI can occur even in seemingly low-risk individuals.
- Standard pre-procedural risk stratification and immediate post-procedural monitoring may not identify all patients at risk for delayed complications.
- This case underscores the potential for late-emerging conduction issues following TAVI.
Implications:
- Extended rhythm monitoring may be warranted for select TAVI patients, even those without apparent pre-procedural risk factors.
- Further research is needed to identify novel predictors of delayed conduction disease after TAVI.
- This case highlights the importance of recognizing atypical presentations of post-TAVI complications.
Related Concept Videos
Aortic Regurgitation III: Medical Management
326
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
326
Mitral Stenosis III: Medical Management
198
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
198
Mitral Regurgitation III: Medical Management
224
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
224

